Celldex Therapeutics (CLDX) Revenue (2010 - 2026)
Celldex Therapeutics' (CLDX) quarterly Revenue came in at $15000.0 in Q1 2026, down 97.84% year-on-year from $695000.0 in Q1 2025, and down 87.6% quarter-over-quarter from $121000.0 in Q4 2025.
Celldex Therapeutics (CLDX) Revenue (2010 - 2026) Analysis & Trends
Celldex Therapeutics' Revenue history runs 17 years deep, the most recent figure standing at $15000.0 for Q1 2026.
- On a quarterly basis, Revenue fell 97.84% year-over-year to $15000.0 in Q1 2026; TTM through Mar 2026 was $866000.0, a 88.54% decrease from a year earlier, with the FY2025 full-year figure at $1.5 million, down 77.99% from the prior year.
- Revenue fell to $15000.0 in Q1 2026 per CLDX's latest filing, from $121000.0 in the prior quarter.
- Across five years, Revenue topped out at $4.1 million in Q4 2023 and bottomed at $15000.0 in Q1 2026.
- The 5-year median for Revenue is $712500.0 (2025), against an average of $1.1 million.
- Across the five-year window, Revenue surged 832.09% in 2024 and tumbled 97.84% in 2026, its largest moves.
- Year by year, Revenue stood at $1.6 million in 2022, then soared by 156.11% to $4.1 million in 2023, then sank by 71.56% to $1.2 million in 2024, then sank by 89.7% to $121000.0 in 2025, then sank by 87.6% to $15000.0 in 2026.
- Per Business Quant, the three latest CLDX Revenue figures stand at $15000.0 (Q1 2026), $121000.0 (Q4 2025), and $730000.0 (Q2 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1.51 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.99 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 3.61 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.56 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Celldex Therapeutics | 1.72 Mn | 1.72 Mn | -1.44 Mn | 15,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15,000.00 |
| Dec 31, 2025 | 121,000.00 |
| Jun 30, 2025 | 730,000.00 |
| Mar 31, 2025 | 695,000.00 |
| Dec 31, 2024 | 1.18 Mn |
| Sep 30, 2024 | 3.19 Mn |
| Jun 30, 2024 | 2.50 Mn |
| Mar 31, 2024 | 156,000.00 |
| Dec 31, 2023 | 4.13 Mn |
| Sep 30, 2023 | 1.52 Mn |
| Jun 30, 2023 | 268,000.00 |
| Mar 31, 2023 | 967,000.00 |
| Dec 31, 2022 | 1.61 Mn |
| Sep 30, 2022 | 407,000.00 |
| Jun 30, 2022 | 163,000.00 |
| Mar 31, 2022 | 174,000.00 |
| Dec 31, 2021 | 334,000.00 |
| Sep 30, 2021 | 153,000.00 |
| Jun 30, 2021 | 3.48 Mn |
| Mar 31, 2021 | 685,000.00 |